Spain – Various medicinal products – Suministro de los medicamentos ILARIS 150 MG./ML solución inyectable, 1 VIAL DE 1 M
Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria awarded €493K to NOVARTIS FARMACÉUTICA S.A. for Construction & Public Works in June 2024 — one of 94 awards this buyer has made, above its typical award size.
Winning supplier
NOVARTIS FARMACÉUTICA S.A.Contract description
Spain – Various medicinal products – Suministro de los medicamentos ILARIS 150 MG./ML solución inyectable, 1 VIAL DE 1 ML (principio activo CANAKINUMAB), TAFINLAR 50 MG. cápsulas duras 28 cápsulas (principio DABRAFENIB), COSENTYX 75 MG. SOL. INYECTABLE JER. PRECARGADA (principio activo SECUKINUMAB), con destino el Servicio de Farmacia del Hospital Universitario Ntra. Sra. de Candelaria.
Related awards · Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria
94 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-354025-2025WERFEN ESPAÑA, S.A.U.€652K02 Jun 2025 Construction
- ocds-ted-696051-2024KERN PHARMA, S.L.€561K15 Nov 2024 Construction
- ocds-ted-693178-2024Roche Farma, S.A.€553K14 Nov 2024 Construction
Other wins · NOVARTIS FARMACÉUTICA S.A.
177 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria and NOVARTIS FARMACÉUTICA S.A. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back